Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. May 27, 2022; 14(5): 409-418
Published online May 27, 2022. doi: 10.4240/wjgs.v14.i5.409
Table 2 Patient and tumour characteristics
Characteristic
LRH, n = 29
ORH, n = 22
P value
Age64 (57.5-67.5)65.5 (59.75-69.25)0.607
Sex 0.688
Male25 (86.2)20 (90.9)
Female4 (13.8)2 (9.1)
Cirrhosis on histology19 (65.5)13 (59.1)0.638
HBsAg-positive27 (93.1)20 (90.9)1.000
Albumin in g/L39 (36-41)36 (34-40)0.109
Total bilirubin in µmol/L17 (13-20)13 (10-16)0.007
International normalized ratio1.1 (1.05-1.20)1.085 (1.055-1.148)0.587
Platelet count as × 109/L123 (99-173)161.5 (115.25-201.00)0.092
Alpha-fetoprotein in IU/mL11 (4.25-288.00)17 (4.0-174.5)0.814
Type of resection 0.055
Sub-segmentectomy19 (65.5)8 (36.4)
Segmentectomy5 (17.2)2 (9.1)
Left lateral sectionectomy2 (6.9)1 (4.5)
Right bisegmentectomy1 (3.4)4 (18.2)
Left hepatectomy +/− extended1 (3.4)1 (4.5)
Right hepatectomy +/− extended1 (3.4)5 (22.7)
Central bisectionectomy0 (0.0)1 (4.5)
Intraoperative ablation1 (3.4)2 (9.1)0.571
Tumour size in cm 0.054
< 12 (6.9)1 (4.5)
≥ 1-215 (51.7)7 (31.8)
≥ 2-35 (17.2)3 (13.6)
≥ 3-45 (17.2)2 (9.1)
≥ 4-51 (3.4)8 (36.4)
≥ 51 (3.4)1 (4.5)
Number of tumours0.295
Single25 (86.2)16 (72.7)
Multiple4 (13.8)6 (27.3)
Tumour location, segment 0.491
I2 (6.9)0 (0.0)
II, III, IV, V, VI14 (48.3)9 (40.9)
VII, VIII13 (44.8)13 (59.1)